IL6 and systemic sclerosis: However, in several pathological conditions associated with increased fibrosis, such as systemic sclerosis [45], IL-6 can act as a profibrotic cytokine, suggesting the increase in collagen deposition observed in CAV1−/− adipose tissue could be related to the elevated levels of IL-6.